发明名称 JASMONATE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER
摘要 A pharmaceutical composition useful for the treatment of cancer in mammals, comprising as the active ingredient a therapeutically effective amount of a jasmonate of the formula: wherein: n is 0,1, or 2; R1 is OH, alkoxy, O-glucosyl, or imino; R2 is OH, O, alkoxy or O-glucosyl; R3, R4 and R5 are H, OH, alkoxy or O-glucosyl; and/or wherein R1 and R2, or R1 and R4 together form a lactone; and further wherein the bonds between C3:C7, C4:C5, and C9:C10 may be double or single bonds; or a derivative of said formula; the derivative having at least one of the following: a lower acyl side chain at C3 (free acid, ester or conjugate); a keto hydroxy (free hydroxy or ester) moiety at the C6 carbon; or an n-pentenyl or n-pentyl side chain at C7. These jasmonates are useful in treating a wide variety of malignancies.
申请公布号 US2002173470(A1) 申请公布日期 2002.11.21
申请号 US20010825347 申请日期 2001.04.04
申请人 FLESCHER ELIEZER;FINGRUT ORIT 发明人 FLESCHER ELIEZER;FINGRUT ORIT
分类号 A61K9/02;A61K9/06;A61K9/08;A61K9/10;A61K9/20;A61K9/48;A61K31/122;A61K31/19;A61K31/215;A61K31/366;A61K45/00;A61K45/06;A61P35/00;A61P35/02;(IPC1-7):A61K31/704;A61K31/365 主分类号 A61K9/02
代理机构 代理人
主权项
地址